A polymorphism in 5-alpha-reductase (SRD5A2) gene shows novel association with prostate cancer

被引：0
|
作者：
Minarik, M.
Benesova, L.
Fantova, L.
Heracek, J.
Urban, M.
Loukola, A.
机构：
[1] Genomac Int, Lab Mol Genet & Oncol, Prague, Czech Republic
[2] Charles Univ Prague, Fac Med 3, Prague, Czech Republic
[3] Univ Helsinki, Finnish Genome Ctr, Helsinki, Finland
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2007年 / 6卷 / 02期
关键词：
D O I：
10.1016/S1569-9056(07)60105-5
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：49 / 49
页数：1
相关论文
共 50 条
  • [31] Genetic Analysis of the SRD5A2 Gene in Indian Patients with 5α-Reductase Deficiency
    Sahu, Ravi
    Boddula, Raman
    Sharma, Pankaj
    Bhatia, Vijayalakshmi
    Greaves, Ronda
    Rao, Sudha
    Desai, Meena
    Wakhlu, Ashish
    Phadke, Shubha
    Shukla, Manoj
    Dabadghao, Preeti
    Mehrotra, Ravi N.
    Bhatia, Eesh
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2009, 22 (03): : 247 - 254
  • [32] Identification and characterization of somatic steroid 5α-reductase (SRD5A2) mutations in human prostate cancer tissue
    Makridakis, N
    Akalu, A
    Reichardt, JKV
    ONCOGENE, 2004, 23 (44) : 7399 - 7405
  • [33] Steroid 5-alpha-reductase type 2 (SRD5A2) V89L and A49T polymorphisms and sporadic prostate cancer risk: a meta-analysis
    Qiaoxin Li
    Yao Zhu
    Jing He
    Mengyun Wang
    Meiling Zhu
    Tingyan Shi
    Lixin Qiu
    Dingwei Ye
    Qingyi Wei
    Molecular Biology Reports, 2013, 40 : 3597 - 3608
  • [34] A CASE OF SEX DEVELOPMENT DISORDER DUE TO A NOVEL MUTATION IN 5 ALFA REDUCTASE (SRD5A2) GENE
    Mengen, Eda
    Kotan, L. Damla
    Yuksel, Bilgin
    Topaloglu, A. Kemal
    HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 370 - 370
  • [35] Associations between polymorphisms in the steroid 5α-reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer
    Salam, MT
    Ursin, G
    Skinner, EC
    Dessissa, T
    Reichardt, JK
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 374 - 374
  • [36] 5-alpha-reductase inhibitors for prostate cancer prevention
    不详
    INTERNATIONAL JOURNAL OF UROLOGY, 2009, 16 (06) : 553 - 553
  • [37] 5-ALPHA-REDUCTASE ACTIVITY IN PROSTATE-CANCER
    RITCHIE, AWS
    HABIB, FK
    BUSUTTIL, A
    NEWSAM, JE
    CHISHOLM, GD
    UROLOGICAL RESEARCH, 1986, 14 (03): : 161 - 161
  • [38] Male pseudohermaphroditism resulting from a novel mutation in the human steroid 5 alpha-reductase type 2 gene (SRD5A2)
    Anwar, R
    Gilbey, SG
    New, JP
    Markham, AF
    JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 1997, 50 (01): : 51 - 52
  • [39] Steroid 5-alpha-reductase type 2 (SRD5A2) V89L and A49T polymorphisms and sporadic prostate cancer risk: a meta-analysis
    Li, Qiaoxin
    Zhu, Yao
    He, Jing
    Wang, Mengyun
    Zhu, Meiling
    Shi, Tingyan
    Qiu, Lixin
    Ye, Dingwei
    Wei, Qingyi
    MOLECULAR BIOLOGY REPORTS, 2013, 40 (05) : 3597 - 3608
  • [40] SRD5A2 gene polymorphisms and the risk of prostate cancer:: A meta-analysis
    Ntais, C
    Polycarpou, A
    Ioannidis, JPA
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (07) : 618 - 624
12345